Welfare Impact of Carbon Dioxide Euthanasia on Laboratory Mice and Rats: A Systematic Review

Introduction

Euthanasia, or provision of a good death, is considered a critical event in an animal's life and it is important for animal well-being that it be conducted in a humane manner. According to international guidelines on research animal euthanasia, a euthanasia procedure should result in rapid and irreversible loss of animal consciousness with minimal distress leading to eventual death (1). It should also be relatively easy, inexpensive, and safe for a trained operator to perform, be accessible to a wide range of possible users, and be esthetically acceptable to those performing or observing the procedure (1). Mice and rats commonly worked with in science and there has been significant interest in recent years in determining the best method(s) for euthanizing these animals in research settings (1). Humane methods are required for euthanizing infant rodents, juveniles, adults, and pregnant dams—as individual animals, in small groups, and sometimes in very large numbers. Research rodents are also euthanized because of spontaneous pain, sickness, injury, or deformity; because humane or experimental endpoints are reached; as a means of population management; and because of environmental emergencies (e.g., flooding or power failures) or depopulation needs (e.g., a biosecurity break). Given the wide variation of reasons for euthanasia, the methods must be safe for a range of different situations. Additionally, because animals are often euthanized at study end to harvest organs for additional investigations, the method of euthanasia should not interfere with the future use of tissues. A further consideration for euthanasia method is that it should not create any hazards for carcass disposal. For example, if cadavers are to be donated for feeding of zoo animals or captive wildlife then the cadavers must be free of substances that may adversely impact other animals. For all of these reasons, carbon dioxide (CO₂) inhalation is the most common technique in use today for euthanasia of laboratory mice and rats (2, 3).

Narcosis following carbon dioxide gas exposure has been long recognized, and CO₂ gas was used historically as a short term anesthetic agent for humans and animals for almost 200 years (3–5). Increasing concentrations of inhaled CO₂ (hypercarbia) induces respiratory and cerebrospinal fluid acidosis, as well as cardiovascular depression, that eventually lead to stupor, with unconsciousness occurring at CO₂ concentrations of ~15–20%. Prolonged exposure to high levels of CO₂ (~40–50%) results in coma, apnea, hyperkalemia, and cardiac arrest (6, 7). While its use as an anesthetic agent in rodents has largely been discontinued for over two decades, CO₂ gas inhalation is used widely around the world for research rodent euthanasia.

Recently, there has been concern that CO₂ inhalation is inhumane as a method of euthanasia for laboratory rodents (8–10). Carbon dioxide is a normal component of inhaled air (0.04%) and internal sensors for CO₂ levels drive respiration in most animals. Labored breathing and fear have been noted in mice when inhaled CO₂ levels are ~5–15%. Fear is thought to be elicited via stimulation of an acid-sensing ion channel 1a located in the amygdala (11). Pain is thought to occur when conscious animals are exposed to high levels of CO₂ (>47%) because of the carbonic anhydrase found within mucosal surfaces of the upper and lower respiratory tree, which converts CO₂ to carbonic acid in the presence of water [reviewed in (9)]. This suggests that there is a potential for discomfort, distress, and/or pain to occur in mice and rats prior to the loss of consciousness when CO₂ gas is used for euthanasia. However, there is conflicting information in published studies regarding the effects of CO₂ gas inhalation on mice and rats during induction for euthanasia. This has resulted in uncertainty regarding the acceptability of inhaled CO₂ for rodent euthanasia and uncertainty by veterinarians and others, such as researchers, regarding which techniques to recommend or use for euthanasia of laboratory mice and rats.

Because euthanasia is deemed a critical responsibility of the laboratory animal veterinarian (1, 12), the International Association of Colleges of Laboratory Animal Medicine (IACLAM; iaclam.org) identified a need to review the literature objectively to determine whether CO₂ gas inhalation meets the definition of euthanasia (1), including evaluating criteria such as time to loss of consciousness and time to death; whether the method is suited to one or multiple animals; and further to compare cost, availability, operator safety, practicality of use in different circumstances, and esthetics of CO₂ use on operators or observers. A task force of board certified laboratory animal veterinarians from around the world was convened to conduct a systematic review of the welfare impact (i.e., any behavioral or physiologic effects related to distress, aversion, and/or pain) of exposure to CO₂ gas (alone or in combination with other agents) for euthanasia of neonatal and adult laboratory mice and rats.

Materials and Methods

Study Design and Systematic Review Protocol

A systematic review of the literature was conducted and reported using the PRISMA guidelines for reporting of systematic reviews [(13) and Supplementary Table 1]. The review protocol was evaluated and registered at http://www.syrcle.nl on May 3, 2017 (14).

Search Strategy and Data Sources

On August 1, 2017, a systematic literature search was conducted concerning CO₂ euthanasia of mice and rats using the following electronic databases: Medline (PubMed), Web of Science, CAB Direct, and Agricola (see Supplementary Table 2). No language or date restrictions were placed aside from database onset dates (Medline, 1950; Web of Science, 1900; CAB Direct, 1904; Agricola, 1970). A research librarian from the University of Guelph was consulted on the search strategy. In addition, reference lists were checked from all identified review articles on euthanasia of laboratory rodents as well as included studies for possible relevant references. An English-only grey (i.e., non-peer reviewed) literature search using Google Scholar was also performed for identifying possible graduate theses, study papers, and abstracts.

Study Selection, Interventions, and Comparators

Primary reviewers (PT, DH, and TK) are board certified laboratory animal veterinarians and members of the IACLAM Taskforce on CO₂ Euthanasia. For Phase 1 screening, one reviewer (PT) initially pre-screened all references based on title alone to remove obvious irrelevant references and all excluded reference titles were checked by two individuals (DH and TK). In cases of conflict, the title was retained for more detailed title and abstract screening. For Phase 2 screening, each reference was assessed by two independent reviewers [PT and (DH or TK)] based on the title and abstract with consensus agreement achieved for all retained papers. Studies were excluded if they were not an in vivo intervention (i.e., experimental or observational) study in mice or rats of any age, if CO₂ inhalation or another inhalant-type anesthesia or euthanasia method was not evaluated, and if publications were from conference proceedings or only available in abstract form and would not permit further data extraction or assessment of risk of bias. Remaining papers were imported to EndNoteX7 (Clarivate Analytics, Philadelphia, PA, USA) and duplicates were removed. For Phase 3 screening, each full-text reference was assessed (PT and DH) using an online systematic review program (Distiller SR, Evidence Partners Inc., Ottawa, ON, Canada), and all conflicts were resolved by consensus. Studies were excluded if they met any of the original three exclusion criteria and/or the study did not measure any outcomes directly relevant to animal welfare or behavior.

Data Extraction and Data Analysis

Data from studies meeting the study selection criteria were independently extracted by two reviewers (PT and DH) using a standardized form, which was tested on 3 pre-selected studies (JS). Discrepancies in data extraction were resolved by consensus.

Study level data included year published, country of origin of the work, authorship, and funding source. Population characteristics included rodent species (mouse, rat, or both), sex (only males, only females, or mixed sex populations), age group of rodents being studied (neonatal vs. post-weaned), stock or strain of the rodent models being evaluated, and whether animals had been used for gas exposure or anesthesia studies in the past. Study design characteristics included the number of experimental and control groups, the number of animals per group, and whether studies were single exposure euthanasia experiments or multiple exposure “anesthesia with recovery” experiments. Intervention characteristics included gas flow rates, duration of exposure, type of gas or euthanasia agent applied, concentration or ratio of gas in mixtures, and other euthanasia treatments. Only quantifiable outcome measures were included, and, where possible, mean (±SE) time of occurrence, number of occurrences, or change in the outcome measure were collected. If a study described pilot data together with definitive data only outcomes from the definitive studies were collected. Continuous outcome measures specifically collected included: heart rate, blood pressure, plasma corticosterone levels, time to loss of posture, time to loss of righting reflex, time to death, time to onset of labored breathing, and change in EEG activity, and dichotomous outcome measures collected included: increased c-fos expression in the brain, urination, defecation, vocalization, seizures, escape behaviors, increased activity on induction, and bleeding from the nose during induction. Individual studies varied in the definitions and methods used for many of these variables. Data were extracted from tables or graphs, if numerical data was not reported.

Risk of Bias and Quality Assessment

Assessment of risk of bias and study quality were conducted independently by two reviewers (PT and DH) using the modified SYRCLE Risk of Bias tool (15) and any disagreements were resolved by consensus. The risk of bias tool was originally developed for studies with separate control and intervention groups. Only one study used separate non-treatment and comparison groups, thus risk of bias was evaluated for all single trial euthanasia-only studies in which there were two or more comparison groups. Reporting of animal randomization, blinding, and sample size calculations was also assessed for all reviewed papers as indicators of study quality.

Results

Study Selection and Characteristics

Results of the search strategy and study selection are presented in Figure 1. Of the 108 full text articles reviewed, 71 articles were excluded as they did not meet eligibility criteria and 37 articles were included. In total, 15 papers were reviewed for mice (16–30), 21 papers for rats (16, 22, 23, 31–48), and 5 papers were reviewed for neonatal rodents (21, 49–52), with three studies reporting results for both adult mice and rats (16, 22, 23) and one study reporting results for both adult female mice and their pups (21, 49–52). Not all studies evaluated euthanasia since welfare concerns in using inhalant gasses for euthanasia primarily revolve around what the animal experiences during the period from onset of exposure to the gas until loss of consciousness. Once an animal is deeply anesthetized, it is by definition insensible to pain and distress as long as the animal does not recover. Thus, some of the studies included in this review evaluated rodent behaviors, physiology, and time to induction with CO₂ or other inhalant gases and then recovered animals for repeated exposures. Detailed study characteristics and findings are presented in Tables 1–3 for adult mice, adult rats, and neonatal rodents, respectively.

FIGURE 1

Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) study flow diagram [modified from (13)].

TABLE 1

Table 1. Characteristics of the 15 adult mouse studies included in the systematic review.

TABLE 2

Table 2. Characteristics of the 21 adult rat studies included in the systematic review.

TABLE 3

Table 3. Characteristics of the five neonatal rodent studies included in the systematic review.

There was considerable diversity in the methods used for exposure to CO₂ and in all but one study, there was no attempt to use a separate control or sham-treated group that wasn't later exposed to a secondary euthanasia or anesthesia intervention within the same study. In no case did three or more studies from different laboratories use similar interventions, species, and outcome measures, or a separate control group, precluding combination of data for meta-analyses. An attempt to re-analyze outcome data was similarly unsuccessful because of the heterogeneity in interventions, outcome measures collected, and their timing.

Risk of Bias and Quality Assessment

Nine of 15 mouse studies (16–19, 21, 25, 27, 28, 30), 7 of 21 rat studies (16, 32, 34, 35, 37, 39, 47), and two of five rodent pup studies (21, 49) (n = 16 separate studies as two evaluated both mice and rats of mice of different ages) were defined as single trial euthanasia studies and were assessed for risk of bias, although none included separate untreated and comparison groups. Other studies that were part of this review had incompatible study designs for the risk of bias assessment (i.e., single observation group, crossover studies, animals used in other gassing experiments, animals used in gas pilot studies prior to the definitive study, animals exposed to repeated subanesthetic gas concentrations or used repeatedly in induction-only trials). The results of the risk of bias assessment are summarized in Figure 2. In general, bias reduction measures were poorly reported by authors and were assessed as “no information.” In 11 of 16 studies, no information was provided about randomization of animals to different comparison groups. In the other five studies, randomization was mentioned; however only one of the studies provided actual evidence of randomization of some of their treatment groups. Sample size or power calculations were only mentioned in 1 of these 16 studies. In half of the 16 studies, animals served as their own controls; however, no information was provided in 5 of 16 studies, and in one study, a treatment group was added after all other portions of the study had been completed, such that no randomization or blinding could occur for this group. Most studies (9 of 16) did not provide information about blinding the treatments provided to animals or blinding those assessing the treatment effects. Because of study designs, treatments could not be blinded in 4 of 16 studies. For this reason, we interpreted both the risk of performance bias and the risk of detection bias to be moderate to high for most studies. No information about study drop-outs was provided in 10 of 16 studies, and this lack of reporting was deemed a moderate to high risk in 3 of 16 studies, in which study drop-outs were noted but not discussed further. In 7 of 16 studies, some results or methods were not fully reported. This included inconsistent reporting of results or methods, reporting of results in figures only (with or without error bars or confidence intervals), and not accounting for re-use of animals between different phases of the study. In 8 of 16 studies, a moderate to high risk for carry-over effects was identified due to re-use of animals between different phases of the study or use of a cross-over design.

FIGURE 2

Figure 2. Risk of bias assessment summary for the 16 single trial studies in adult mice and rats, and rodent pups (16–19, 21, 25, 27, 28, 30, 32, 34, 35, 37, 39, 47, 49).

The overall quality assessment for the 37 papers included in this systematic review is shown in Figure 3. In general, randomization of animals to study groups was reported in 12 of 37 studies (32%), although, as mentioned above, only one paper provided actual evidence of randomization. Reporting of blinding for data collection or assessment occurred in 10 of 37 studies (27%), and reporting of a sample size calculation occurred in 4 of 37 studies (11%).

FIGURE 3

Figure 3. Quality assessment summary for the 37 papers included in this systematic review. (a) Reporting of any randomization, (b) reporting of any blinding, and (c) sample size calculation performed.

The risk of confirmation bias was determined to be high for some of the rat studies in which the same rats were re-used between studies conducted within one laboratory (anesthesia- or exposure-only type studies).

Effects of Carbon Dioxide Inhalation on Adult Mice

The study characteristics for mice were remarkably diverse, emphasizing that comparisons were difficult to make. Of the 15 papers included for review for mice, one evaluated exposure to sublimation of dry ice (16), a technique no longer considered humane for rodent euthanasia because of the variability of CO₂ gas production and the serious risk of freezing burns in animals if they touch the surface of dry ice (−78.5°C) (1). Eight studies (53%) evaluated outcomes in mice following a single exposure trial in which euthanasia resulted, while six studies (40%) evaluated outcomes following repeated exposures to CO₂ or other inert or anesthetic gasses. When repeated exposures occurred, they ranged from 3 to 50 or more exposures, sometimes over a 4 month test period. Multiple strains of mice were evaluated across the different studies (although generally only one per study) in males (47%), females (33%), or both (20%) sexes of mice. Animals ranged in age from 8 weeks to over 24 weeks of age and studies sometimes were conducted opportunistically (2 of 15 studies), using animals remaining after other experiments conducted by other research groups had been completed. The nature of the previous work with the animals was generally not specified nor was the interval or time period always defined between the previous studies and the euthanasia/anesthesia studies. One study (7%) incorporated untreated controls into the study design, four studies (27%) had no control comparator group, and three studies (20%) used baseline values from the same animals as internal controls while seven (47%) induction-only studies used a variation of a cross-over designs in which mice were exposed to at least two or more gasses or inhalant agents, but not necessarily all tested agents.

Studies evaluated, tested, and reported exposures to CO₂ and other inhalant gasses in a variety of ways. Exposure to CO₂ or other inert or inhalant anesthetic gas was expressed as a percentage when delivered by face mask, and as volume displacement rate (VDR; 40% of studies) and/or as flow rate (FR; 40% of studies) when delivered into a chamber or cage. Volume displacement rate is considered the most accurate exposure method for calculating CO₂ delivery into a chamber because of the marked variability in cage and chamber size (1). Because chamber dimensions were not routinely provided FR could not be converted to VDR. Similarly, gas flow patterns within the chamber will markedly affect the outcome following gas exposure, e.g., use of a gas diffuser and the specific location of gas introduction into the chamber, since all gasses studied are heavier than air. Some studies evaluated different VDRs or FRs of CO₂, some compared one or more VDR/FR of CO₂ with one or more inert or inhalant anesthetic gas and some studies compared one or more VDR/FR/percentage of CO₂ with other physical or chemical methods of euthanasia, including pentobarbital sodium, potassium chloride, cervical dislocation, and decapitation. One study evaluated the effects of different VDRs of CO₂ with or without premedication with acepromazine or midazolam (30) and one study evaluated the effects of different flow rates of CO₂ when given with differing ambient light intensities (28). Flow or volume displacement rates of carbon dioxide evaluated ranged from 0.2 L/min to 15–100%.

A wide range of animal welfare-related outcome measures were reported, and the outcomes and direction of effect are listed in Table 1. When determining welfare impacts of exposure to CO₂ or another method, the most important considerations are time to loss of consciousness and signs or changes suggestive of pain, discomfort or distress that are seen prior to loss of consciousness, since anything that occurs after this time will not be perceived by the animal. Assessment of unconsciousness was not conducted in the same way in studies that assessed this parameter. Loss of posture (LOP) or “nose down,” and loss of righting reflex (LORR) were all used by different research groups. At high flow rates, LOP occurs almost simultaneously with LORR; however, LOP can occur 5–20 s prior to LORR during induction for anesthesia. Assessment of LORR requires an experimental set-up that permits the observer to handle and manipulate the animal.

Of the 20 outcome measures evaluated in mice across the 15 studies, 10 were behavioral and included one or more of chamber escape attempts, “anxiety/pain” behaviors, jumping, increased activity, distance traveled, vocalization, rearing, urination, defecation, and labored breathing. One outcome measure was a trained response requiring repeated exposures to CO₂ and other agents over training and definitive trials, that is, using approach-avoidance techniques. The remaining nine outcomes were physiologic in nature and included one or more of time to loss of posture or nose down, time to loss of righting reflex, heart rate, mean blood pressure, plasma corticosterone level, plasma ACTH level, time to loss of EEG signal, time to loss of visual evoked potential, and time to death.

In terms of behavioral findings, mice exposed to isoflurane demonstrated more movement in the chamber during induction than mice exposed to different VDRs of CO₂, but there was no difference in escape attempts, pain or anxiety behaviors, including urination, defecation, and rearing, or ultrasonic vocalizations by mice induced with either CO₂ or isoflurane (16–18, 22, 23, 28–30). In one study, labored breathing was noted in mice exposed to CO₂ (20–50% FR) prior to LOP (25), but was not reported in a subsequent study by the same researchers using 20% VDR CO₂ or isoflurane exposure (27).

In studies evaluating physiologic parameters in mice, time to LORR following CO₂ exposure were consistently in three circumstances: when compared to other tested agents, such as isoflurane in oxygen (18, 27), for increasing VDRs or flow rates of CO₂ (17, 28, 30), and when CO₂ was combined with nitrous oxide (N₂O) (29). Use of a sedative, such as acepromazine or midazolam, prior to administering CO₂ did not shorten time to LORR (30). Heart rates and mean blood pressure increased from baseline prior to the onset of ataxia or LORR in all mice exposed to VDRs of CO₂ between 15 and 100% and for mice exposed to isoflurane in oxygen (17, 18). There was no difference in peak heart rate or mean blood pressure with different VDRs of CO₂ (15–100%), although, time to peak cardiovascular parameters was shorter with increasing VDRs of CO₂ (17). Peak heart rates were higher for mice exposed to isoflurane compared with different VDRs of CO₂, although peak mean blood pressure did not differ for mice exposed to CO₂ vs. isoflurane (18). No differences were noted in plasma ACTH levels between mice exposed to different VDRs of CO₂ vs. isoflurane (17, 18) and increased plasma corticosterone levels were noted for mice exposed to isoflurane for induction vs. CO₂ alone (28). Time to loss of EEG signal and loss of visual evoked potential was fastest for mice exposed to 100% CO₂ by facemask (vs. 70% CO₂) (19).

Five studies did not examine time to loss of consciousness, anesthesia or euthanasia following exposure to CO₂ or other inert or inhalant gasses, but instead evaluated effects of repeated exposure to different VDRs or FRs of CO₂ in approach-avoidance studies. These results were sometimes compared to argon (alone or in combination with CO₂), carbon monoxide (CO), isoflurane, and/or sevoflurane (20, 22–24, 26). VDRs, FRs, and percentage inhalant gas and rates of carrier oxygen were significantly different between these studies making comparisons difficult. In one study evaluating the impact of CO₂ exposure (53% FR) compared to argon (99% FR) and mixtures of CO₂ with argon, the time dwelling and time to withdrawal from chambers in which mice were exposed to gasses were shorter for mice exposed to CO₂ alone or in combination with argon (22). In a subsequent study by this group comparing different FRs of CO₂ (25.5–50.8% FR) alone to argon (99% FR), there was no difference in the chamber dwelling time and time to withdrawal from the chamber between any of the treatment groups (23). Guedes et al. (20) compared pairs of gasses (sevoflurane to CO₂, sevoflurane to isoflurane, and isoflurane to CO₂) and found no difference in dwelling time in the gas-only chambers between any of the pairs of gasses. When time to withdrawal from the chamber for CO₂ (20% VDR) exposure was compared to isoflurane in oxygen vs. isoflurane drops on a cotton ball, withdrawal times were longest for isoflurane in oxygen and shorter for CO₂ and isoflurane drops (26). However, upon re-exposure to the same agents, time to withdrawal from the chamber was shortest for isoflurane in oxygen (26). Finally, when mice were exposed 50 or more times to different gasses, including 70% FR CO₂ vs. argon vs. CO vs. isoflurane, latency to withdraw from a chamber in which they received food rewards always occurred when CO₂ chamber concentrations reached 13.5–18.2%, latency time to leave was equal for isoflurane and CO, and latencies were longest for argon (24).

Effects of Carbon Dioxide Inhalation on Adult Rats

Similar to what was noted for mice, the study characteristics were highly diverse for rats. Of the 21 papers included for review for rats, one evaluated exposure to sublimation of dry ice (16), a procedure no longer considered acceptable, as mentioned above. This paper was not considered further. Ten studies (48%) evaluated outcomes in rats following a single definitive exposure trial in which euthanasia resulted (although in 3 of these studies, pilot studies involving gas exposures were also conducted using the same study animals), while another 10 studies (48%) evaluated outcomes following repeated exposures to CO₂ or other inert or anesthetic gasses. When repeated exposures occurred, the number of prior exposures was often not specified. Eight of the studies (38% of the total) (31, 40–45, 48) were conducted by one lab and, as mentioned, many of the same rats were re-used in multiple studies with results published in separate papers. Studies were conducted largely in Wistar or Sprague-Dawley (SD) rats and in both sexes, although generally only one sex per study (71% were conducted in males only, 19% in females only, 5% in both sexes, and 5% did not specify animal sex). In these studies, animals ranged in age from 7 to 52 weeks. Similar to mice, details concerning previous experimental work with the rats was poorly specified and animals were used opportunistically in at least four studies. None of the rat studies incorporated untreated controls into the study design, four studies (19%) had no control comparator group, and 15 studies (71%) used baseline values from the same animals as internal controls and/or used the same animals in pilot trials. In seven of the euthanasia studies (33%), rats had been previously surgically instrumented with catheters or telemetry transducers under anesthesia (which included ketamine/xylazine, methohexitone, isoflurane, or sodium pentobarbital). Only one of these studies (34) re-exposed rats to the same anesthetic agent (isoflurane) during the definitive euthanasia trials.

Similar to studies in mice, a range of methods was used for reporting exposures to CO₂ and other gasses. Some studies evaluated prefilled chambers of CO₂ vs. different VDRs or FRs of CO₂, some compared one or more VDR/FR of CO₂ (sometimes mixed with oxygen or nitrogen) compared to one or more inert (e.g., argon, nitrogen) or inhalant anesthetic gas (isoflurane, sevoflurane), and one study compared one or more VDR or FR of CO₂ with pentobarbital sodium euthanasia (34). One study evaluated the effects of different VDRs of CO₂ with or without premedication with acepromazine (37). Flow or volume displacement rates of carbon dioxide evaluated ranged from 3% VDR to 100% CO₂ chamber prefill.

A wide range of animal welfare-related outcome measures were reported, and the outcomes and direction of effect are listed in Table 2. For rat studies, assessment of unconsciousness was not conducted in the same way between studies, and both loss of posture (LOP) and loss of righting reflex (LORR) were used in different studies.

Of the 21 outcome measures evaluated in rats across the 21 studies, 10 were behavioral and included at least one of: chamber escape attempts, jumping/rearing, increased activity, distance traveled, vocalization, urination, defecation, labored breathing/gasping/head shaking, nasal bleeding, and seizures. One of the outcome measures assessed was a trained response requiring repeated exposures to CO₂ and other agents over training and definitive trials using approach-avoidance techniques. The remaining 10 outcomes were physiologic in nature and included at least one of: time to LOP, time to LORR, heart rate, mean blood pressure, plasma corticosterone level, plasma ACTH level, serum glucose levels, time to isoelectric EEG signal, changes in electromyograph signal, and time to death.

For behavioral outcomes, several studies reported no adverse outcomes in rats (32, 38, 47), while other researchers reported nasal bleeding (36) or gasping (35, 39) at very high exposures of CO₂ (60% FR or greater). Use of acepromazine as a sedative prior to administering CO₂ did not provide any apparent extra benefit, as these researchers did not observe any urination, defecation, vocalization in rats exposed to CO₂ at 6 L/min FR (37). Similarly, in the same study, tachypnea was seen in rats with increasing chamber concentrations of CO₂, regardless of whether rats had been premedicated with acepromazine as a sedative (37).

In euthanasia studies evaluating physiologic responses, time to LORR, times were shortest for argon when supplied at 50% VDR or higher (32); however, seizures were reported in rats prior to loss of consciousness when very high exposures to argon (or nitrogen) occurred (46). Otherwise, LORR was fastest when rats were placed in novel chambers prefilled with 100% CO₂ (35, 36, 38, 39, 46, 47). Only one of the euthanasia studies compared the effects of CO₂ to isoflurane induction, followed by CO₂ (34), and inductions (LORR) were noted to be slower with isoflurane compared with 20% CO₂ VDR. Heart rates and mean blood pressure decreased from baseline in all rats exposed to VDRs of CO₂ between 10 and 100% and for rats exposed to isoflurane in oxygen (32, 34, 35, 39, 46). In all studies in which EEGs were evaluated, time to isoelectric EEG and time to death were shortest for exposures to CO₂ of 20% VDR or greater (34, 35, 39, 46, 47). In one study, exposure to argon at 50% VDR was compared to exposure to CO₂ at 10% VDR, and time to death was faster for rats exposed to argon (32). No differences were noted in serum glucose in rats exposed to CO₂ at 6 L/min when compared with rats exposed to the same level of CO₂ but pre-treated with either acepromazine or pentobarbital; however, the rats exposed first to pentobarbital had higher serum levels of ACTH and corticosterone (37).

Ten studies reviewed did not examine time to loss of consciousness, anesthesia or euthanasia following exposure to CO₂ or other inert or inhalant gasses, but instead evaluated effects of repeated exposure to different VDRs or FRs of CO₂ or other inert or anesthetic gasses in approach-avoidance studies. These results were sometimes compared to argon (alone or in combination with CO₂ and/or oxygen) or isoflurane and/or sevoflurane (22, 23, 31, 40, 41, 43–46, 48). VDRs, FRs, and percentage inhalant gas and rates of carrier oxygen were also significantly different between these studies making comparisons difficult. Similar to mice, in one study evaluating the impact of CO₂ exposure (53% FR) compared to argon (99% FR) and mixtures of CO₂ with argon, the dwelling time in the chamber and time to withdrawal from chamber in which rats were exposed to gasses were shorter for rats exposed to CO₂ alone or in combination with argon (22). In a subsequent study by this group comparing different FRs of CO₂ (25.5–50.8% FR) alone to argon (99% FR), there was no difference in the dwelling time and time to withdrawal between any of the treatment groups (23). When different flow rates of argon alone were compared, chamber dwelling time (i.e., latency to leave) decreased with increasing concentrations of argon (41). When aversion-avoidance was evaluated for isoflurane compared to sevoflurane, both agents were determined to be aversive and aversion increased with re-exposure (31). Further, when different CO₂ VDRs or FRs were compared in an approach-avoidance paradigm, chamber dwelling times (i.e., latency to leave) were reduced as CO₂ concentrations increased (40, 43, 45) or when compared to exposure to isoflurane (48).

Effects of Carbon Dioxide Inhalation on Rodent Pups

When evaluating the effects of carbon dioxide inhalation on rodent pups, a variety of study designs and comparators were used. Five studies examined the effect of CO₂ gas administration, isoflurane exposure, cervical dislocation, or sodium pentobarbital administered by intraperitoneal (IP) injection to the dam or by intraplacental injection (fetal mice only) on neonatal and fetal rodent pups. Four of the studies evaluated euthanasia of mouse pups (neonatal or embryonic) (21, 49, 50, 52) and one study evaluated the effects of CO₂ gas exposure on neonatal rat pups (51). One study discussed the prolonged time to death of neonatal pups after exposure to halothane, a halogenated anesthetic no longer available in many countries (21). Multiple stocks and strains of mice were evaluated by the different neonatal mouse studies and SD stock and F344 strain were evaluated in the neonatal rat study.

The welfare outcomes measured for the rodent pups or fetuses for these studies included time to loss of righting reflex (LORR; pups only), time to cardiac arrest, and time to death (Table 3). Administration of sodium pentobarbital IP to postnatal day (PND) 8–14 mouse pups resulted in a faster LORR than for exposure of this same age group to CO₂ gas; however, time to cardiac arrest was faster for CO₂ gas exposure (21). Fetal mouse death was fastest following intraplacental administration of sodium pentobarbital compared to either administration of sodium pentobarbital IP to dams or exposure of dams to CO₂ gas (49). Very young mouse pups (PND 0–6) of both sexes required prolonged exposures to CO₂ to induce death (up to 60 min for PND 0)—if shorter times were used it was common for pups to recover when exposed to room air (50). Further, inbred strains were more resistant to the lethal effects of CO₂ gas inhalation than outbred stocks (50). Exposure to high concentrations of isoflurane gas in oxygen for up to 30 min resulted in anesthesia of PND 1–2 mouse pups, but 24% of pups recovered after 30–120 min of room air exposure (52). Rat pups also required prolonged exposures to CO₂ gas for euthanasia, although rats succumbed more quickly at PND 0 (35 min) than mice (60 min) (51). In summary, these findings indicate that very prolonged exposures are required when CO₂ exposure is used for euthanasia of mouse or rat pups that are PND 6 or younger.

Discussion

Death is a critical and permanent juncture in the course of any animal's life. Therefore, there is significant interest in ensuring that methods used for euthanasia of laboratory mice and rats are humane. Although many organizations have developed guidelines and recommendations for euthanasia of laboratory rodents [for example, (1, 53)], to date, these guidelines have not been based on a systematic review of the evidence available. This systematic review is the first to examine the evidence for the welfare impact of CO₂ inhalation for euthanasia of laboratory mice and rats alone or in comparison with other euthanasia methods.

Available Evidence and Quality

Studies evaluating the behavioral and physiologic effects of CO₂ gas inhalation for euthanasia of laboratory mice, rats, and rodent pups were highly heterogenous in approach. Heterogeneity was caused by differences in the populations (sex of animal, different stocks and strains, prior use of animals in previous experiments, ages of adult animals), the interventions studied (CO₂ gas; other anesthetic or inert gasses; physical methods; chemical methods; rate, method, and reporting of gas introduction and maintenance; age of perinatal rodent pups), and the outcome measures evaluated within and between studies. Most of the reported outcomes for single trial euthanasia studies in laboratory mice and rats showed no adverse effect of CO₂ on behavioral or physiologic outcomes when administered to animals in a chamber at 70% VDR or less, and responses were generally no different from baseline. Evidence indicating discomfort prior to induction for euthanasia is present for CO₂ gas when supplied to mice or rats in 100% prefilled chambers as gasping or tachypnea. Distress ultrasonic vocalizations (26.5 kHz) were also noted in mice during single trial euthanasia studies when exposed to CO₂ in 100% prefilled chambers but not at lower VDRs. Similar distress ultrasonic vocalizations were noted when mice were induced with isoflurane in oxygen. When exposed to subanesthetic concentrations of CO₂ gas over multiple training trials, mice and rats demonstrated avoidance behaviors in test trials. Avoidance behaviors were also seen in mice and rats exposed to subanesthetic concentrations of isoflurane and sevoflurane with multiple training trials. Reliability and overall interpretation of these findings is hampered by a number of limitations. In the one study in mice comparing CO₂ euthanasia (100% prefill) to physical methods, the time to loss of EEG signal was similar between CO₂, KCl injection, cervical dislocation, and decapitation.

Not all of the studies in the body of literature that are frequently cited as evidence of CO₂ aversion evaluated physiologic or behavioral variables preceding euthanasia but rather evaluated parameters in response to exposures to subanesthetic CO₂ or other gasses. Some of the studies reviewed evaluated behaviors that required repeated exposures to gas for reliable performance of a given behavior, and mice and rats in many studies were re-used between pilot and definitive phases, between different trials within the same study, and in some cases, between different experiments conducted within the same lab and published in separate papers. These repeat exposure experimental designs were likely used in an attempt to reduce the numbers of animals needed, an important 3Rs consideration. While repeat exposure studies can inform the research community about aspects of animal welfare, they cannot be considered as strictly equivalent to single trial euthanasia studies.

Appropriate reporting of methods is essential for interpreting study bias and quality in all biomedical research publications and to ensure reproducibility (54, 55). This has been emphasized repeatedly to the research community with publication of guidelines to support conduct and reporting of high quality experiments (56, 57). Our risk of bias assessment indicated generally poor or unclear bias in most of the studies for which this tool could be used. Furthermore, the overall study quality assessment suggested generally poor quality of evidence for the welfare effect of CO₂ and other inhaled gasses for euthanasia of laboratory mice and rats, when considering sample size determination, and risks of performance and detection bias. Sample size calculations force research teams to define a primary outcome for their study a priori and the effect size needed to detect a difference between groups. When this is missing or poorly done, it becomes difficult to interpret the relevance of effects noted. For example, a statistically significant result within a small group of animals (e.g., a 5–10 s difference in loss of righting reflex between groups) may not be biologically relevant when the entire population is considered (58). Performance and detection bias are particularly critical for euthanasia procedures, in that euthanasia is a procedure that many people find distasteful and challenging to perform. Recently, a clear demonstration of bias occurred when study participants were asked to score the quality of observed loss of consciousness of mice and rats. The scoring differed when viewers were told that animals were being euthanized or anesthetized. (59). This demonstrates that it is essential that appropriate blinding occur when collecting and then assessing euthanasia outcomes.

Because of these general shortcomings in study design and conduct, the results of this systematic review indicate that there is insufficient evidence to permit an unbiased assessment of the impact of CO₂ inhalation during euthanasia on welfare indicators in laboratory mice and rats. Further, while studies of repeated exposures to CO₂ gas suggest that CO₂ induction using prefilled containers may result in short periods of distress, induction with accepted inhalant anesthetic agents, including isoflurane and sevoflurane in oxygen, also are aversive to laboratory mice and rats. The aversion/avoidance differences between treatment groups are small under highly controlled laboratory conditions, and positive vs. negative differences in apparent aversion/avoidance between these agents and CO₂ are not always clear cut. For example, repeated exposure to isoflurane was evaluated as being more aversive than repeated exposure to CO₂ gas (26, 48, 60).

Further studies are needed to accurately assess the impact of inhalant euthanasia methods, such as exposure to CO₂ gas on laboratory mice and mouse welfare, including the impact of euthanizing mice and rats in their home cages. A strategy for further research in this area has recently been published (61).

Conclusion

There is insufficient evidence to permit an unbiased assessment of the overall impact of CO₂ inhalation during euthanasia on welfare indicators in laboratory mice and rats. Additional well-designed, unbiased, and adequately powered studies are needed to accurately assess the welfare impact of CO₂ gas euthanasia method for laboratory mice and rats and to identify alternative techniques that represent a significant improvement or benefit to animal welfare.

Data Availability Statement

All datasets presented in this study are included in the article/Supplementary Material.

Author Contributions

All authors contributed to conception and design of the study. PT, JL, and MR-H developed the SR protocol and submitted to SYRCLE for approval. PT, DH, and TK conducted the literature screening. PT and JS developed the data extraction questionnaire. PT and DH conducted the data extraction and ROB analysis. PT wrote the first draft of the manuscript. All authors contributed to manuscript revision, and read and approved the submitted version.

Funding

Publication of this paper was supported by IACLAM.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The reviewer MRL declared a past collaboration with the author DH to the handling editor.

Acknowledgments

We would like to thank Deirdre Stuart and Brianna Mercer, summer research assistants at the University of Guelph, for technical support with the literature review process.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fvets.2020.00411/full#supplementary-material

Supplementary Table 1. PRISMA Checklist.

Supplementary Table 2. Comprehensive Search Strategy.

References

1. AVMA. AVMA Guidelines for the Euthanasia of Animals. 2020 ed. American Veterinary Medical Association (2020). Available online at: https://www.avma.org/kb/policies/documents/euthanasia.pdf (accessed January 25, 2020).

Google Scholar

2. Boivin GP, Hickman DL, Creamer-Hente MA, Pritchett-Corning KR, Bratcher NA. Review of CO₂ as a euthanasia agent for laboratory rats and mice. J Am Assoc Lab Anim Sci. (2017) 56:491–9.

PubMed Abstract | Google Scholar

3. Merriman JE. The role of carbon dioxide in anaesthesia. Can Anaesth Soc J. (1995) 2:273–80. doi: 10.1007/BF03016171

CrossRef Full Text | Google Scholar

4. Wilson SR. Carbon dioxide in anaesthesia. Br J Anaesth. (1926) 3:112–8. doi: 10.1093/bja/3.3.112

CrossRef Full Text | Google Scholar

5. Bert P. La Pression Barometrique. Paris: G. Masson (1978). 610 p.

Google Scholar

6. Permentier K, Vercammen S, Soetaert S, Schellemans C. Carbon dioxide poisoning: a literature review of an often forgotten cause of intoxication in the emergency department. Int J Emerg Med. (2017) 10:14. doi: 10.1186/s12245-017-0142-y

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Langford NJ. Carbon dioxide poisoning. Toxicol Rev. (2005) 24:229–35. doi: 10.2165/00139709-200524040-00003

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Conlee KM, Stephens ML, Rowan AN, King LA. Carbon dioxide for euthanasia: Concerns regarding pain and distress, with special reference to mice and rats. Lab Anim. (2005) 39:137–61. doi: 10.1258/0023677053739747

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Hawkins P, Prescott MJ, Carbone L, Dennison N, Johnson C, Makowska IJ, et al. A good death? Report of the Second Newcastle Meeting on laboratory animal euthanasia. Animals (Basel). (2016) 6:50. doi: 10.3390/ani6090050

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Axiak Flammer S, Eskes C, Kohler I, Ochiang Pernet A, Jakob P, Marahrens M, et al. Alternatives to carbon dioxide - taking responsibility for humanely ending the life of animals. Animals (Basel). (2019) 9:482. doi: 10.3390/ani9080482

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Ziemann AE, Allen JE, Dahdaleh NS, Drebot II, Coryell M, Wunsch AM, et al. The amygdala is a chemosensor that detects carbon dioxide and acidosis to elicit fear behavior. Cell. (2009) 139:1012–21. doi: 10.1016/j.cell.2009.10.029

PubMed Abstract | CrossRef Full Text | Google Scholar

12. National Research Council. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: The National Academies Press (2011). 105 p.

Google Scholar

13. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and metaAnalyses: the PRISMA statement. PLoS Med. (2009) 6:e1000097. doi: 10.1371/journal.pmed.1000097

CrossRef Full Text | Google Scholar

14. Turner PV, Sargeant J, Hickman D, Kurosawa TM, Mercer B, Ritskes M, et al. Protocol for Systematic Review of Carbon Dioxide in Laboratory Rodents. The Netherlands: SYRCLE (2017). Available online at: https://issuu.com/radboudumc/docs/the_use_of_carbon_dioxide_as_a_meth (accessed January 25, 2020).

Google Scholar

15. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol. (2014) 14:43. doi: 10.1186/1471-2288-14-43

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Blackshaw JK, Fenwick DC, Beattie AW, Allan DJ. The behaviour of chickens, mice and rats during euthanasia with chloroform, carbon dioxide and ether. Lab Anim. (1988) 22:67–75. doi: 10.1258/002367788780746674

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Boivin GP, Bottomley MA, Dudley ES, Schiml PA, Wyatt CN, Grobe N. Physiological, behavioral, and histological responses of male C57BL/6N mice to different CO₂ chamber replacement rates. J Am Assoc Lab Anim Sci. (2016) 55:451–61.

PubMed Abstract | Google Scholar

18. Boivin GP, Bottomley MA, Schiml PA, Goss L, Grobe N. Physiologic, behavioral, and histologic responses to various euthanasia methods in C57BL/6NTac male mice. J Am Assoc Lab Anim Sci. (2017) 56:69–78.

PubMed Abstract | Google Scholar

19. Cartner SC, Barlow SC, Ness TJ. Loss of cortical function in mice after decapitation, cervical dislocation, potassium chloride injection, and CO₂ inhalation. Comp Med. (2007) 57:570–3.

Google Scholar

20. Guedes SR, Valentim AM, Antunes LM. Mice aversion to sevoflurane, isoflurane and carbon dioxide using an approach-avoidance task. Appl Anim Behav Sci. (2017) 189:91–7. doi: 10.1016/j.applanim.2017.01.012

CrossRef Full Text | Google Scholar

21. Klaunberg BA, O'Malley J, Clark T, Davis JA. Euthanasia of mouse fetuses and neonates. Contemp Top Lab Anim Sci. (2004) 43:29–34.

Google Scholar

22. Leach MC, Bowell VA, Allan TF, Morton DB. Aversion to gaseous euthanasia agents in rats and mice. Comp Med. (2002) 52:249–57.

PubMed Abstract | Google Scholar

23. Leach MC, Bowell VA, Allan TF, Morton DB. Measurement of aversion to determine humane methods of anaesthesia and euthanasia. Anim Welf. (2004) 13:S77–86.

Google Scholar

24. Makowska IJ, Vickers L, Mancell J, Weary DM. Evaluating methods of gas euthanasia for laboratory mice. Appl Anim Behav Sci. (2009) 121:230–5. doi: 10.1016/j.applanim.2009.10.001

CrossRef Full Text | Google Scholar

25. Moody CM, Chua B, Weary DM. The effect of carbon dioxide flow rate on the euthanasia of laboratory mice. Lab Anim. (2014) 48:298–304. doi: 10.1177/0023677214546509

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Moody CM, Weary DM. Mouse aversion to isoflurane versus carbon dioxide gas. Appl Anim Behav Sci. (2014) 158:95–101. doi: 10.1016/j.applanim.2014.04.011

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Moody CM, Makowska IJ, Weary DM. Testing three measures of mouse insensibility following induction with isoflurane or carbon dioxide gas for a more humane euthanasia. Appl Anim Behav Sci. (2015) 163:183–7. doi: 10.1016/j.applanim.2014.11.010

CrossRef Full Text | Google Scholar

28. Powell K, Ethun K, Taylor DK. The effect of light level, CO₂ flow rate, and anesthesia on the stress response of mice during CO₂ euthanasia. Lab Anim. (2016) 45:386–95. doi: 10.1038/laban.1117

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Thomas AA, Flecknell PA, Golledge HD. Combining nitrous oxide with carbon dioxide decreases the time to loss of consciousness during euthanasia in mice - refinement of animal welfare? PLoS One. (2012) 7:e32290. doi: 10.1371/journal.pone.0032290

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Valentine H, Williams WO, Maurer KJ. Sedation or inhalant anesthesia before euthanasia with CO₂ does not reduce behavioral or physiologic signs of pain and stress in mice. J Am Assoc Lab Anim Sci. (2012) 51:50–7.

Google Scholar

31. Boulanger-Bertolus J, Nemeth G, Makowska IJ, Weary DM. Rat aversion to sevoflurane and isoflurane. Appl Anim Behav Sci. (2014) 164:73–80. doi: 10.1016/j.applanim.2014.12.013

CrossRef Full Text | Google Scholar

32. Burkholder TH, Niel L, Weed JL, Brinster LR, Bacher JD, Foltz CJ. Comparison of carbon dioxide and argon euthanasia: effects on behavior, heart rate, and respiratory lesions in rats. J Am Assoc Lab Anim Sci. (2010) 49:448–53.

PubMed Abstract | Google Scholar

33. Chisholm J, De Rantere D, Fernandez NJ, Krajacic A, Pang DS. Carbon dioxide, but not isoflurane, elicits ultrasonic vocalizations in female rats. Lab Anim. (2013) 47:324–7. doi: 10.1177/0023677213493410

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Chisholm JM, Pang DS. Assessment of carbon dioxide, carbon dioxide/oxygen, isoflurane and pentobarbital killing methods in adult female Sprague-Dawley rats. PLoS One. (2016) 11:e0162639. doi: 10.1371/journal.pone.0162639

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Coenen AM, Drinkenburg WH, Hoenderken R, van Luijtelaar EL. Carbon dioxide euthanasia in rats: oxygen supplementation minimizes signs of agitation and asphyxia. Lab Anim. (1995) 29:262–8. doi: 10.1258/002367795781088289

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Danneman PJ, Stein S, Walshaw SO. Humane and practical implications of using carbon dioxide mixed with oxygen for anesthesia or euthanasia of rats. Lab Anim Sci. (1997) 47:376–85.

Google Scholar

37. Hackbarth H, Küppers N, Bohnet W. Euthanasia of rats with carbon dioxide - animal welfare aspects. Lab Anim. (2000) 34:91–6. doi: 10.1258/002367700780578055

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Hewett TA, Kovacs MS, Artwohl JE, Bennett BT. A comparison of euthanasia methods in rats, using carbon dioxide in prefilled and fixed flow rate filled chambers. Lab Anim Sci. (1993) 43:579–82.

PubMed Abstract | Google Scholar

39. Hickman DL, Fitz SD, Bernabe CS, Caliman IF, Haulcomb MM, Federici LM, et al. Evaluation of low versus high volume per minute displacement CO₂ methods of euthanasia in the induction and duration of panic-associated behavior and physiology. Anim. (2016) 6:E45. doi: 10.3390/ani6080045

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Kirkden RD, Niel L, Stewart SA, Weary DM. Gas killing of rats: the effect of supplemental oxygen on aversion to carbon dioxide. Anim Welf. (2008) 17:79–87.

Google Scholar

41. Makowska IJ, Niel L, Kirkden RD, Weary DM. Rats show aversion to argon-induced hypoxia. Appl Anim Behav Sci. (2008) 114:572–81. doi: 10.1016/j.applanim.2008.04.005

CrossRef Full Text | Google Scholar

42. Niel L, Weary DM. Behavioural responses of rats to gradual-fill carbon dioxide euthanasia and reduced oxygen concentrations. Appl Anim Behav Sci. (2006) 100:295–308. doi: 10.1016/j.applanim.2005.12.001

CrossRef Full Text | Google Scholar

43. Niel L, Weary DM. Rats avoid exposure to carbon dioxide and argon. Appl Anim Behav Sci. (2007) 107:100–9. doi: 10.1016/j.applanim.2006.08.002

CrossRef Full Text | Google Scholar

44. Niel L, Kirkden RD, Weary DM. Effects of novelty on rats' responses to CO₂ exposure. Appl Anim Behav Sci. (2008) 111:183–94. doi: 10.1016/j.applanim.2007.06.004

CrossRef Full Text | Google Scholar

45. Niel L, Stewart SA, Weary DM. Effect of flow rate on aversion to gradual-fill carbon dioxide exposure in rats. Appl Anim Behav Sci. (2008) 109:77–84. doi: 10.1016/j.applanim.2007.02.004

CrossRef Full Text | Google Scholar

46. Sharp J, Azar T, Lawson D. Comparison of carbon dioxide, argon, and nitrogen for inducing unconsciousness or euthanasia of rats. J Am Assoc Lab Anim Sci. (2006) 45:21–5.

Google Scholar

47. Smith W, Harrap SB. Behavioural and cardiovascular responses of rats to euthanasia using carbon dioxide gas. Lab Anim. (1997) 31:337–46. doi: 10.1258/002367797780596130

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Wong D, Makowska IJ, Weary DM. Rat aversion to isoflurane versus carbon dioxide. Biol Lett. (2013) 9:20121000. doi: 10.1098/rsbl.2012.1000

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Muñoz-Mediavilla C, Cámara JA, Salazar S, Segui B, Sanguino D, Mulero F, et al. Evaluation of the foetal time to death in mice after application of direct and indirect euthanasia methods. Lab Anim. (2016) 50:100–7. doi: 10.1177/0023677215600626

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Pritchett K, Corrow D, Stockwell J, Smith A. Euthanasia of neonatal mice with carbon dioxide. Comp Med. (2005) 55:275–81.

PubMed Abstract | Google Scholar

51. Pritchett-Corning KR. Euthanasia of neonatal rats with carbon dioxide. J Am Assoc Lab Anim Sci. (2009) 48:23–7.

PubMed Abstract | Google Scholar

52. Seymour TL, Nagamine CM. Evaluation of isoflurane overdose for euthanasia of neonatal rats. J Am Assoc Lab Anim Sci. (2016) 55:321–3.

Google Scholar

53. Canadian Council on Animal Care. Guidelines on Euthanasia of Animals Used in Science. (2010). Available online at: https://www.ccac.ca/Documents/Standards/Guidelines/Euthanasia.pdf (accessed February 11, 2020).

Google Scholar

54. Macleod MR, Lawson McLean A, Kyriakopoulou A, Serghiou S, de Wilde A, Sherratt N, et al. Risk of bias in reports of in vivo research: a focus for improvement. PLoS Biol. (2015) 13:e1002273. doi: 10.1371/journal.pbio.1002273

CrossRef Full Text | Google Scholar

55. Reichlin TS, Vogt L, Würbel H. The researchers' view of scientific rigor - survey on the conduct and reporting of in vivo research. PLoS One. (2016) 11:e0165999. doi: 10.1371/journal.pone.0165999

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. (2010) 8:e1000412. doi: 10.1371/journal.pbio.1000412

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. The ARRIVE Guidelines 2019: Updated Guidelines for Reporting Animal Research. (2019). Available online at: https://www.biorxiv.org/content/10.1101/703181v1 (accessed February 11, 2020).

Google Scholar

58. Faraone SV. Interpreting estimates of treatment effects. Implications for managed care. Pharm Therapeut. (2008) 33:700–11.

Google Scholar

59. Baker BA, Hickman DL. Bias in rating of rodent distress during anesthesia induction for anesthesia compared with euthanasia. J Am Assoc Lab Anim Sci. (2018) 57:143–56.

PubMed Abstract | Google Scholar

60. Marquardt N, Feja M, Hünigen H, Plendl J, Menken L, Fink H, et al. Euthanasia of laboratory mice: are isoflurane and sevoflurane real alternatives to carbon dioxide? PLoS ONE. (2018) 13:e0203793. doi: 10.1371/journal.pone.0203793

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Steiner AR, Flammer SA, Beausoleil NJ, Berg C, Bettschart-Wolfensberger R, Pinillos RG, et al. Humanely ending the life of animals: Research priorities to identify alternatives to carbon dioxide. Anim. (2019) 9:E911. doi: 10.3390/ani9110911

PubMed Abstract | CrossRef Full Text | Google Scholar